This event has been rescheduled from it's original date of 9/14/23.
In Part 1 of Semaglutide and GLP-1 Medications in Weight-Inclusive Care, attendees heard from our panel about mechanisms, use cases, dosages and access, as well as the side effects and impacts of these medications. The conversation also dove into things to consider when working from a weight-inclusive lens.
It was clear that the community is ready for an even deeper dive into the conversation and we have so many more questions to address, so we have opened a Part 2!
Dr. Lisa Erlanger will join us for an even deeper dive into the use of semaglutide and GLP-1 medications.
In application for 1 CEU for RDNs.
weightinclusivenutrition.com